Back to Results
First PageMeta Content
Stock market / Galapagos NV / NYSE Euronext / Euronext / Prospectus / Forward-looking statement / Evidence / Cystic fibrosis / Short / Business / Financial economics / Investment


Regulated information 12 May 2015 NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA
Add to Reading List

Document Date: 2015-05-12 02:04:00

Open Document

File Size: 157,15 KB

Share Result on Facebook

City

Mechelen / /

Company

Galapagos Group / CONTACT Galapagos NV / Fidelta / Galapagos NV / /

Continent

Europe / /

Country

Belgium / France / United States / Netherlands / Croatia / Canada / United Kingdom / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

Belgium headquarters / /

IndustryTerm

feefor-service subsidiary / biotechnology / /

MedicalCondition

idiopathic pulmonary fibrosis / rheumatoid arthritis / Crohn’s disease / ulcerative colitis / cystic fibrosis / inflammation / inflammatory diseases / /

Organization

U.S. Securities and Exchange Commission / /

Person

Elizabeth Goodwin / /

/

Position

Head of Corporate Communications / /

Product

RA / GLPG1690 / Crohn / GPR84 / GLPG1837 / /

Technology

biotechnology / /

SocialTag